Gehad M. Subaiea - Concepedia

Author

Gehad M. Subaiea

Also Known As

, G. M. Subaiea, G. Subaiea, Gehad M Subaiea, Gehad M. Subaiea, Gehad Mohammed Subaiea, Gehad Muhammed Subaiea, Gehad Subaiea, GehadM Subaiea, M Subaiea

Publications

684

Citations

H-Index

Concepts

All Affiliations

University of Rhode Island University of Ha'il Thamar University JSS Academy of Higher Education and Research Saudi Arabian Monetary Authority

About

Gehad M. Subaiea is an author at University of Rhode Island specializing in medicine, pharmacology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	259
2	Public Health	2	2	107
3	Engineering	1	1	26
4	Health Sciences	1	1	27
5	Natural Sciences	1	1	30

Gehad M. Subaiea

Publications

606

Citations

H-Index

Page 1

	Year	Citations
Infantile exposure to lead and late‐age cognitive decline: Relevance to AD Syed Waseem Bihaqi, Azadeh Bahmani, Gehad M. Subaiea, Alzheimer s & Dementia	2013	93
Energy drinks and population health: consumption pattern and adverse effects among Saudi population Gehad M. Subaiea, Ali F. Altebainawi, Thamir M. Alshammari BMC Public Health NutritionDietary ExposurePublic Health NutritionConsumer ResearchEnergy Drinks	2019	55
Parental perceptions, attitudes and acceptance of childhood immunization in Saudi Arabia: A cross sectional study Thamir M. Alshammari, Gehad M. Subaiea, Talib Hussain, Vaccine VaccinationMaternal ImmunizationSaudi ArabiaChild HealthPediatrics	2017	52
Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice Gehad M. Subaiea, Lina Adwan, Aseef H. Ahmed, Neurobiology of Aging Alzheimer's DiseaseCognitive FunctionsMedicineDementiaTolfenamic Acid	2013	46
Pomegranate Extract Modulates Processing of Amyloid-β Precursor Proteinin an Aged Alzheimer’s Disease Animal Model Aijaz Ahmed, Gehad M. Subaiea, Ahmed M. Eid, Current Alzheimer Research	2014	46
Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers Lina Adwan, Gehad M. Subaiea, Nasser H. Zawia Neuropharmacology Alzheimer's DiseaseBiochemistryMedicineDementiaLead-induced Upregulation	2014	45
Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model Miriam Dash, Assaad A. Eid, Gehad M. Subaiea, NeuroToxicology Developmental BiologyGeneticsDevelopmental ToxicologyHuman Tau GeneToxicology	2016	33
Tolfenamic acid reduces tau and <scp>CDK</scp>5 levels: implications for dementia and tauopathies Lina Adwan, Gehad M. Subaiea, Riyaz Basha, Journal of Neurochemistry	2014	32
Tolfenamic Acid Interrupts the De Novo Synthesis of the &#946;-Amyloid Precursor Protein and Lowers Amyloid Beta Via a Transcriptional Pathway Lina Adwan, Riyaz Basha, Maen Abdelrahim, Current Alzheimer Research -Amyloid Precursor ProteinMolecular BiologyTolfenamic AcidDe Novo SynthesisNeurochemical Biomarkers	2011	30
Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer’s Disease Syed Waseem Bihaqi, Bothaina Alansi, Anwar Masoud, Current Alzheimer Research	2018	28

Page 1